Revofil Fine is the Soft Touch grade of the Revofil peptide dermal filler range from Caregen in South Korea, developed for the correction of superficial wrinkles, fine lines and caved scars. It is placed in the superficial dermis with a 30G 1/2 inch needle and lasts 10 months on average before a touch up. The monophasic, homogeneous gel contains 23 mg/mL of reticulated hyaluronic acid, cross-linked and of non-animal origin, together with two biomimetic peptides, oligopeptide-72 (CG-Boostrin) and oligopeptide-50 (CG-Glamerin), and is intended for professional use.
主要优势: Revofil Fine
- Reticulated hyaluronic acid 23 mg/mL of non-animal origin in a monophasic homogeneous gel
- Oligopeptide-72 strongly inhibits hyaluronidase, which extends the duration of the gel in the skin
- Oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid
- The lightest grade in the range, placed in the superficial dermis with a fine 30G 1/2 inch needle
- Lasts 10 months on average before touch up
- High elasticity and stable fluidity in dynamic mechanical analysis
- Biodegradable gel, slowly absorbed over time
- Available as a single 1 mL pre-filled syringe or as a 2 x 1 mL pack
适应症与专业用途
主要适应症
- Correction of superficial wrinkles
- Correction of fine lines
- Correction of caved scars
专业用途
For professional use. Revofil Fine is administered by practitioners trained in dermal filler injection technique, and is not for retail sale or self-administration. It is the most superficially placed grade in the range, injected into the superficial dermis with a 30G 1/2 inch needle. Within the range, the tear troughs, fine lines, temporal region and upper cheeks are shared with Revofil Plus, while the cheek and hollow cheek are covered by all three grades.
治疗部位
- Tear troughs
- Fine lines
- Temporal region
- Upper cheeks
- Cheeks and hollow cheeks
适用患者
For adult patients seeking correction of superficial wrinkles, fine lines or caved scars, as assessed by a qualified practitioner. In a clinical study, 172 patients aged 20 to 56 were treated across the range, 30 of them with Revofil Fine; all were satisfied after injection without allergic effects, and affirmative results were reached in 99% of cases.
作用原理: Revofil Fine
Revofil combines cross-linked hyaluronic acid with peptide technology, giving the gel both biphasic and monophasic physical characteristics. Rather than carrying phosphate-buffered saline between the cross-linked hyaluronic acid molecules, it carries a higher concentration of free hyaluronic acid linked to peptide, which increases the stability of the gel. The two peptides do distinct jobs: oligopeptide-72 strongly inhibits hyaluronidase, the enzyme that breaks the gel down, which extends how long it lasts in the skin; oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid, increasing skin tightness. In vitro, hyaluronidase activity decreased by 90% and collagen 1 and hyaluronic acid synthesis in human fibroblasts increased by 81% and 45%, along with protection against oxidative stress and UV-induced cell damage.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVOFIL 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。
常见问题
How does Revofil Fine differ from Revofil Plus and Revofil Ultra?
Placement, not concentration. All three carry 23 mg/mL reticulated hyaluronic acid with the same two peptides. Revofil Fine is the Soft Touch grade, placed in the superficial dermis with a 30G needle and lasting 10 months on average. Revofil Plus is the Sub Touch grade for mid to deep dermis and Revofil Ultra the Deep Touch grade for deep dermis and subcutaneous, both with 27G needles and both lasting 12 months on average.
Does Revofil Fine do more than fill the wrinkle?
Yes. Alongside the hyaluronic acid gel, oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid. In human fibroblasts it increased collagen 1 synthesis by 81% and hyaluronic acid synthesis by 45%, together with an antioxidant effect against oxidative chemical damage and protection against UVB-induced cell death.
更多产品: Caregen
诊所替代选择
继续浏览
Revofil Fine is the Soft Touch grade of the Revofil peptide dermal filler range from Caregen in South Korea, developed for the correction of superficial wrinkles, fine lines and caved scars. It is placed in the superficial dermis with a 30G 1/2 inch needle and lasts 10 months on average before a touch up. The monophasic, homogeneous gel contains 23 mg/mL of reticulated hyaluronic acid, cross-linked and of non-animal origin, together with two biomimetic peptides, oligopeptide-72 (CG-Boostrin) and oligopeptide-50 (CG-Glamerin), and is intended for professional use.
主要优势: Revofil Fine
- Reticulated hyaluronic acid 23 mg/mL of non-animal origin in a monophasic homogeneous gel
- Oligopeptide-72 strongly inhibits hyaluronidase, which extends the duration of the gel in the skin
- Oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid
- The lightest grade in the range, placed in the superficial dermis with a fine 30G 1/2 inch needle
- Lasts 10 months on average before touch up
- High elasticity and stable fluidity in dynamic mechanical analysis
- Biodegradable gel, slowly absorbed over time
- Available as a single 1 mL pre-filled syringe or as a 2 x 1 mL pack
适应症与专业用途
主要适应症
- Correction of superficial wrinkles
- Correction of fine lines
- Correction of caved scars
专业用途
For professional use. Revofil Fine is administered by practitioners trained in dermal filler injection technique, and is not for retail sale or self-administration. It is the most superficially placed grade in the range, injected into the superficial dermis with a 30G 1/2 inch needle. Within the range, the tear troughs, fine lines, temporal region and upper cheeks are shared with Revofil Plus, while the cheek and hollow cheek are covered by all three grades.
治疗部位
- Tear troughs
- Fine lines
- Temporal region
- Upper cheeks
- Cheeks and hollow cheeks
适用患者
For adult patients seeking correction of superficial wrinkles, fine lines or caved scars, as assessed by a qualified practitioner. In a clinical study, 172 patients aged 20 to 56 were treated across the range, 30 of them with Revofil Fine; all were satisfied after injection without allergic effects, and affirmative results were reached in 99% of cases.
作用原理: Revofil Fine
Revofil combines cross-linked hyaluronic acid with peptide technology, giving the gel both biphasic and monophasic physical characteristics. Rather than carrying phosphate-buffered saline between the cross-linked hyaluronic acid molecules, it carries a higher concentration of free hyaluronic acid linked to peptide, which increases the stability of the gel. The two peptides do distinct jobs: oligopeptide-72 strongly inhibits hyaluronidase, the enzyme that breaks the gel down, which extends how long it lasts in the skin; oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid, increasing skin tightness. In vitro, hyaluronidase activity decreased by 90% and collagen 1 and hyaluronic acid synthesis in human fibroblasts increased by 81% and 45%, along with protection against oxidative stress and UV-induced cell damage.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVOFIL 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Revofil Fine differ from Revofil Plus and Revofil Ultra?
Placement, not concentration. All three carry 23 mg/mL reticulated hyaluronic acid with the same two peptides. Revofil Fine is the Soft Touch grade, placed in the superficial dermis with a 30G needle and lasting 10 months on average. Revofil Plus is the Sub Touch grade for mid to deep dermis and Revofil Ultra the Deep Touch grade for deep dermis and subcutaneous, both with 27G needles and both lasting 12 months on average.
Does Revofil Fine do more than fill the wrinkle?
Yes. Alongside the hyaluronic acid gel, oligopeptide-50 up-regulates the patient's own collagen and hyaluronic acid. In human fibroblasts it increased collagen 1 synthesis by 81% and hyaluronic acid synthesis by 45%, together with an antioxidant effect against oxidative chemical damage and protection against UVB-induced cell death.